These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12433366)

  • 21. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
    Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
    J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
    Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
    J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ; Grufman P; Sandberg JK; Tegnesjö A; Kärre K
    J Immunol; 1998 Nov; 161(9):4499-505. PubMed ID: 9794374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
    Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
    J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligands for murine NKG2D display heterogeneous binding behavior.
    Carayannopoulos LN; Naidenko OV; Kinder J; Ho EL; Fremont DH; Yokoyama W
    Eur J Immunol; 2002 Mar; 32(3):597-605. PubMed ID: 11857333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-amino-acid variant of the H60 CD8 epitope generates specific immunity with diverse TCR recruitment.
    Ryu SJ; Jeon JY; Chang J; Sproule TJ; Roopenian DC; Choi EY
    Mol Cells; 2012 Apr; 33(4):393-9. PubMed ID: 22441676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens.
    Yoshimura Y; Yadav R; Christianson GJ; Ajayi WU; Roopenian DC; Joyce S
    J Immunol; 2004 Jun; 172(11):6666-74. PubMed ID: 15153482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens.
    Malarkannan S; Horng T; Eden P; Gonzalez F; Shih P; Brouwenstijn N; Klinge H; Christianson G; Roopenian D; Shastri N
    Immunity; 2000 Sep; 13(3):333-44. PubMed ID: 11021531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cutaneous malignancy by gammadelta T cells.
    Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
    Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
    Grufman P; Sandberg JK; Wolpert EZ; Kärre K
    J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class I-like genes in cattle, MHCLA, with similarity to genes encoding NK cell stimulatory ligands.
    Larson JH; Rebeiz MJ; Stiening CM; Windish RL; Beever JE; Lewin HA
    Immunogenetics; 2003 Apr; 55(1):16-22. PubMed ID: 12679856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
    Cerwenka A; Bakker AB; McClanahan T; Wagner J; Wu J; Phillips JH; Lanier LL
    Immunity; 2000 Jun; 12(6):721-7. PubMed ID: 10894171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural regulation of immunity to minor histocompatibility antigens.
    Robertson NJ; Chai JG; Millrain M; Scott D; Hashim F; Manktelow E; Lemonnier F; Simpson E; Dyson J
    J Immunol; 2007 Mar; 178(6):3558-65. PubMed ID: 17339452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells.
    Chen J; Ellison FM; Eckhaus MA; Smith AL; Keyvanfar K; Calado RT; Young NS
    J Immunol; 2007 Apr; 178(7):4159-68. PubMed ID: 17371972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients.
    Kwun J; Hu H; Schadde E; Roenneburg D; Sullivan KA; DeMartino J; Burlingham WJ; Knechtle SJ
    J Immunol; 2007 Dec; 179(12):8016-25. PubMed ID: 18056341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH
    Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.
    Takaki R; Hayakawa Y; Nelson A; Sivakumar PV; Hughes S; Smyth MJ; Lanier LL
    J Immunol; 2005 Aug; 175(4):2167-73. PubMed ID: 16081783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for target cell recognition by natural killer cells.
    Diefenbach A; Raulet DH
    Immunol Rev; 2001 Jun; 181():170-84. PubMed ID: 11513138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
    Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
    J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minor H antigens: genes and peptides.
    Simpson E; Scott D; James E; Lombardi G; Cwynarski K; Dazzi F; Millrain JM; Dyson PJ
    Eur J Immunogenet; 2001 Oct; 28(5):505-13. PubMed ID: 11881817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.